Skip to main content
Close Menu
Primary links
Life
Family Matters
Generation Next
Adults & Aging
HemAware Junior
Mind & Body
Fitness & Nutrition
Taking Charge
Pain Management
Alternative Treatments
Women's Health
Women's Bleeding Disorders
Carriers
Bleeding Disorders A-Z
Hemophilia A&B
Von Willebrand Disease
Rare Bleeding Disorders
HIV
Hepatitis C
Research & Treatment
Surgery & Transplants
Novel Technologies
Researcher Profiles
Fighting for You
Insurance
Blood Safety
Advocacy
Ask a Social Worker
Community Pulse
Chapter Roundup
Global Focus
My Journey
Community in Action
75th Anniversary
NBDF in Action
Sponsored Content
×
Close
Paid Advertisement.
NBDF does not endorse products or manufacturers.
Zip Locksmith
Subscribe
Select your language
English
Spanish
Search
Menu
Breadcrumb
Home
Search Stories
Search Stories
Hemophilia B—an excellent candidate for gene therapy
Gene therapy aims to address the root cause of hemophilia B and help people produce stable and protective levels of...
Read More
Sponsored Content
Bleeding Disorders Conference Preview
The National Hemophilia Foundation’s (NHF) 74th Annual Bleeding Disorders Conference (BDC) will take place August 25-27, 2022. After two years...
Read More
NBDF in Action
Anticipo de la Conferencia sobre Trastornos Hemorrágicos
La 74.° Conferencia Anual sobre Trastornos Hemorrágicos (BDC) de la Fundación Nacional de Hemofilia (National Hemophilia Foundation, NHF) tendrá lugar...
Read More
NHF in Action
Are Nasal Swabs in At-Home COVID Tests Safe for People with Bleeding Disorders?
It’s 2022 and COVID-19 is, unfortunately, still around. Of course, things have gotten better, but the pandemic still trudges along...
Read More
Taking Charge
¿Los hisopos nasales de las pruebas de COVID en el hogar son seguros para las personas con trastornos hemorrágicos?
Estamos en el año 2022 y desafortunadamente la COVID-19 sigue entre nosotros. Por supuesto, las cosas han mejorado, pero la...
Read More
Taking Charge
What’s the Difference Between Plasmapheresis and Therapeutic Plasma Exchange?
When people with hemophilia develop an inhibitor—about 1/3 to 1/5 of people with severe hemophilia A and 1% to 4%...
Read More
Taking Charge
¿Cuál es la diferencia entre la plasmaféresis y el recambio plasmático terapéutico?
Cuando las personas con hemofilia presentan un inhibidor (alrededor de 1/3 a 1/5 de las personas con hemofilia A grave...
Read More
Taking Charge
Ask a Social Worker: How Can I Help Someone with Hemophilia Who’s in Prison?
Ask a Social Worker is a monthly column featuring questions from the community and answers from members of NHF’s Social...
Read More
Ask a Social Worker
Pregunte a un trabajador social: ¿Cómo puedo ayudar a alguien con hemofilia que está en prisión?
Pregunte a un trabajador social es una columna mensual en la que aparecen preguntas de la comunidad y respuestas de...
Read More
Ask a Social Worker
Record-Keeping Tips for the Bleeding Disorders Community
People with hemophilia know that it requires effort and diligence to maintain a healthy lifestyle while living with a bleeding...
Read More
Taking Charge
Consejos sobre el mantenimiento de registros para la comunidad de personas con trastornos hemorrágicos
Las personas con hemofilia saben que se requiere esfuerzo y diligencia para mantener un estilo de vida saludable mientras se...
Read More
Taking Charge
Challenge Accepted Season 2
Challenge Accepted is a reality TV web series created by Genentech to tackle the unspoken issues of people living with...
Read More
Sponsored Content
Load More
Need Information about Bleeding Disorders?
Contact The Neil Frick Resource Center (NFRC)
Contact NFRC